BioSpace News Archive

Zikani Therapeutics, a company leveraging its unique TURBO-ZM TM platform to develop novel ribosome modulating agents (RMAs) for the treatment of rare, nonsense mutation-driven diseases, today announced the appointment of Vijay Modur, M.D., Ph.D., as its Chief Scientific and Medical Officer to lead the company

INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, today announced today the pricing of its underwritten public offering of an aggregate of 2,173,914 shares of its common stock at a public offering price of $10.00 per share. In addition, INmune has granted the underwriters an over-allotment op

Elligo Health Research ®, a healthcare-enabling research organization, is launching their fully realized System of Accelerated Research (SOAR) model for decentralized (DCTs) and hybrid trial models with fully remote monitoring capabilities. Only Elligo has developed as a continuum of technologies and data science capabilities; Elligo’s SOAR™ model expands patient access to

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second-quarter 2020 financial results on Thursday, July 30, 2020 after the financial markets close. The company will host a conference call and webcast at 5:30 p.m. ET. To access the call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International). The conference call will be webcast live and a link to the webcast can be accessed through Vertex’

Real-world Datasets Will Be Used to Advance Research in Multiple Therapeutic Areas across Neurology, Hematology, and Rare Disease

Sandra S. Garrett, Ph.D. CEO of MediMergent, LLC of Rockville, MD, was recently named to the National Small Business Association (NSBA) Leadership Council

The OrthoForum, a nationwide network of privately owned orthopaedic practices known for its pillars of benchmarking, networking, innovation and advocacy, announced a collaboration with the American Academy of Orthopaedic Surgeons (AAOS), naming the AAOS Registry Program as the organization’s recommended registries for its members.

ITOCO INC. (OTC Pink:ITMC) is pleased to announce the launch of https://blog.itoco.net

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today held its annual meeting of shareholders. As part of the meeting, shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and elected KPMG LLP, as the Company’s auditors for the current fiscal year. All candidates proposed for the position of directors were elected in the follow

Strengthens Kronos’ clinical development pipeline and long-term commitment to leverage transcriptional regulatory networks to unlock historically undruggable targets in oncology Includes two clinical stage SYK inhibitors (entospletinib and lanraplenib) with initial development planned in biomarker defined subset of acute myelogenous leukemia